4//SEC Filing
SEIDENBERG BETH C 4
Accession 0001104659-25-123597
CIK 0001994702other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 11:43 AM ET
Size
7.6 KB
Accession
0001104659-25-123597
Insider Transaction Report
Form 4
SEIDENBERG BETH C
Director10% Owner
Transactions
- Purchase
Common Stock
2025-12-18$7.50/sh+133,333$999,998→ 869,317 total(indirect: See Footnote)
Holdings
- 3,787,940(indirect: See Footnote)
Common Stock
- 16,634
Common Stock
Footnotes (3)
- [F1]Shares held directly by Westlake BioPartners Opportunity Fund I, L.P. ("Westlake Opportunity"). The general partner of Westlake Opportunity is Westlake BioPartners Opportunity GP I, LLC ("Westlake Opportunity GP I"). The Reporting Person is the managing director of Westlake Opportunity GP I and has sole voting and dispositive control over Westlake Opportunity GP I, and disclaims beneficial ownership of the shares held by Westlake Opportunity except to the extent of the Reporting Person's pecuniary interest therein, if any.
- [F2]Shares held directly by Westlake BioPartners Fund I, L.P. ("Westlake I"). The general partner of Westlake I is Westlake BioPartners GP I, LLC ("Westlake GP I"). The Reporting Person is the managing director of Westlake GP I and has sole voting and dispositive control over Westlake GP I, and disclaims beneficial ownership of the shares held by Westlake I except to the extent of the Reporting Person's pecuniary interest therein, if any.
- [F3]Represents a restricted stock unit award of common stock, which will vest in full on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
Documents
Issuer
Kyverna Therapeutics, Inc.
CIK 0001994702
Entity typeother
Related Parties
1- filerCIK 0001184592
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 11:43 AM ET
- Size
- 7.6 KB